Moderate-risk patients with diabetes treated with a sulfonylurea appear to be at a higher risk of major adverse cardiovascular events than those who receive a dipeptidyl peptidase-4 (DPP-4) inhibitor, ...
Sulfonylureas are an older class of type 2 diabetes therapy but remain the most commonly prescribed antidiabetic drug after metformin. Patients taking metformin for type 2 diabetes (T2D) who switch to ...
So, Why Are Clinicians Still Using Sulfonylureas? Given the continuing concerns about sulfonylureas and the new guidelines from the ACP, the Medscape poll results made me wonder why about one half of ...
People with type 2 diabetes treated with metformin plus a sulfonylurea with high affinity for cardiac mitochondrial adenosine triphosphate–sensitive potassium (mitoK ATP) channels, such as glyburide ...
Background and goal: Sulfonylureas are a class of oral medications used to manage blood glucose levels in patients with type 2 diabetes. These drugs increase insulin production regardless of blood ...
An estimated 26 million Americans suffer from type-2 diabetes, with about 1 million new cases diagnosed each year. This serious disease can lead to numerous adverse health effects, including ...
With the passage of the 2010 Affordable Care Act (ACA), the Centers for Medicare & Medicaid Services (CMS) is required to report performance data on physicians billing Medicare through the Physician ...
DailyUpdates 30th March: According to WHO, there are some 130 million diagnosed diabetics in the world and the long term consequences of diabetes such as diabetic nephropathy are becoming increasingly ...
To increase our power to identify novel pharmacogenomic loci for sulfonylureas, we extended this effort to include several additional diverse-ancestry cohorts with a high prevalence of sulfonylurea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results